Cart
sales@molnova.com
1-Aminobenzotriazole
CAS No. 1614-12-6
1-Aminobenzotriazole ( ABT;3-Aminobenzotriazole )
Catalog No. M20548 CAS No. 1614-12-6
1-Aminobenzotriazole (ABT) is a non-specific cytochrome P450 (CYP) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 37 | In Stock |
|
| 100MG | 43 | In Stock |
|
| 200MG | 51 | In Stock |
|
| 500MG | 91 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Aminobenzotriazole
-
NoteResearch use only not for human use.
-
Brief Description1-Aminobenzotriazole (ABT) is a non-specific cytochrome P450 (CYP) inhibitor.
-
Description1-Aminobenzotriazole (ABT) is a non-specific cytochrome P450 (CYP) inhibitor.
-
SynonymsABT;3-Aminobenzotriazole
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1614-12-6
-
Formula Weight134.14
-
Molecular FormulaC6H6N4
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (931.86 mM)
-
SMILESNn1nnc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mugford C A Mortillo M Mico B A et al. 1-Aminobenzotriazole-Induced Destruction of Hepatic and Renal Cytochromes P450 in Male Sprague-Dawley Rats[J]. Fundamental and Applied Toxicology 1992 19(1):43-49.
molnova catalog
related products
-
Rhodionin
Rhodionin and rhodionin can inhibit cytochrome P450 2D6 non-competitively with high specificity which could have implications for interactions with co-administered drugs; they can significantly suppress the elevation of the postprandial blood triglyceride level suggests that they may be to the treatment of lifestyle-related diseases such as hyperlipidemia and exogeneous obesity and to health foods.
-
Bergapten
5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo.
-
TAK-700 (Orteronel)
Orteronel(TAK-700) was selected as a candidate for clinical evaluation.
